Hunan Hansen Pharmaceutical Co. Ltd. (002412) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Hunan Hansen Pharmaceutical Co. Ltd.

Why is Hunan Hansen Pharmaceutical Co. Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 6.03% and Operating profit at 11.30% over the last 5 years

NET PROFIT(Q) At CNY 13.52 MM has Fallen at -70.99%
OPERATING CASH FLOW(Y) Lowest at CNY 171.58 MM
INTEREST COVERAGE RATIO(Q) Lowest at 9,139.09

Underperformed the market in the last 1 year

The stock has generated a return of 2.56% in the last 1 year, much lower than market (China Shanghai Composite) returns of 15.17%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Hunan Hansen Pharmaceutical Co. Ltd. for you?

Medium Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Hunan Hansen Pharmaceutical Co. Ltd.

0.48%

0.55

31.93%

China Shanghai Composite

15.17%

1.02

14.86%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

6.03%

EBIT Growth (5y)

11.30%

EBIT to Interest (avg)

45.43

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

-0.15

Sales to Capital Employed (avg)

0.45

Tax Ratio

13.46%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

8.69%

ROE (avg)

9.10%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.43

EV to EBIT

10.67

EV to EBITDA

9.21

EV to Capital Employed

1.51

EV to Sales

2.82

PEG Ratio

Dividend Yield

ROCE (Latest)

14.12%

ROE (Latest)

8.27%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company

DEBT-EQUITY RATIO (HY)

Lowest at -19.02 %

RAW MATERIAL COST(Y)

Fallen by -4.05% (YoY

CASH AND EQV(HY)

Highest at CNY 941.47 MM

-17What is not working for the Company

NET PROFIT(Q)

At CNY 13.52 MM has Fallen at -70.99%

OPERATING CASH FLOW(Y)

Lowest at CNY 171.58 MM

INTEREST COVERAGE RATIO(Q)

Lowest at 9,139.09

NET SALES(Q)

At CNY 231.94 MM has Fallen at -10.18%

OPERATING PROFIT(Q)

Lowest at CNY 31.33 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 13.51 %

PRE-TAX PROFIT(Q)

Lowest at CNY 32.67 MM

Here's what is working for Hunan Hansen Pharmaceutical Co. Ltd.

Debt-Equity Ratio

Lowest at -19.02 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Cash and Eqv

Highest at CNY 941.47 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost

Fallen by -4.05% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Hunan Hansen Pharmaceutical Co. Ltd.

Net Profit

At CNY 13.52 MM has Fallen at -70.99%

over average net sales of the previous four periods of CNY 46.61 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Interest Coverage Ratio

Lowest at 9,139.09

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Pre-Tax Profit

At CNY 32.67 MM has Fallen at -52.78%

over average net sales of the previous four periods of CNY 69.18 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Operating Cash Flow

Lowest at CNY 171.58 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales

At CNY 231.94 MM has Fallen at -10.18%

over average net sales of the previous four periods of CNY 258.22 MM

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit

Lowest at CNY 31.33 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 13.51 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at CNY 32.67 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)